Skip to main content
Top
Published in: Journal of Nuclear Cardiology 2/2020

01-04-2020 | Review Article

Chagas heart disease: A contemporary review

Authors: Alejandro Velasco, MD, Carlos A. Morillo, MD

Published in: Journal of Nuclear Cardiology | Issue 2/2020

Login to get access

Abstract

Chagas disease is caused by a parasite infection endemic of the Americas. Traditionally observed in rural areas of Latin America, current migration trends have turned Chagas disease into a global epidemic. Acute infection is rarely severe and once it resolves, some patients can develop cardiomyopathy as part of the chronic form many years later. Multiple factors related with both the host and the parasite determine the susceptibility and progression to cardiomyopathy. Current imaging techniques are able to identify cardiac autonomic denervation, perfusion abnormalities, and myocardial fibrosis at an early of stage before the development of symptoms. The prognosis of patients with Chagasic cardiomyopathy remains poor and life-threatening ventricular arrhythmias can occur at an early stage. Treatment of chronic Chagas cardiomyopathy is challenging with a great need for more studies in the field.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lewinsohn R. Carlos Chagas and the discovery of Chagas’ disease (American trypanosomiasis). J R Soc Med. 1981;74:451-5.PubMedPubMedCentral Lewinsohn R. Carlos Chagas and the discovery of Chagas’ disease (American trypanosomiasis). J R Soc Med. 1981;74:451-5.PubMedPubMedCentral
3.
go back to reference Bocchi EA, Bestetti RB, Scanavacca MI, Cunha Neto E, Issa VS. Chronic Chagas heart disease management: from etiology to cardiomyopathy treatment. J Am Coll Cardiol. 2017;70:1510-24.PubMed Bocchi EA, Bestetti RB, Scanavacca MI, Cunha Neto E, Issa VS. Chronic Chagas heart disease management: from etiology to cardiomyopathy treatment. J Am Coll Cardiol. 2017;70:1510-24.PubMed
4.
5.
go back to reference Yamagata Y, Nakagawa J. Control of Chagas disease. Adv Parasitol. 2006;61:129-65.PubMed Yamagata Y, Nakagawa J. Control of Chagas disease. Adv Parasitol. 2006;61:129-65.PubMed
6.
7.
go back to reference Bern C, Kjos S, Yabsley MJ, Montgomery SP. Trypanosoma cruzi and Chagas’ disease in the united states. Clin Microbiol Rev. 2011;24:655-81.PubMedPubMedCentral Bern C, Kjos S, Yabsley MJ, Montgomery SP. Trypanosoma cruzi and Chagas’ disease in the united states. Clin Microbiol Rev. 2011;24:655-81.PubMedPubMedCentral
8.
go back to reference Bern C, Montgomery SP. An estimate of the burden of Chagas disease in the united states. Clin Infect Dis. 2009;49:e52-4.PubMed Bern C, Montgomery SP. An estimate of the burden of Chagas disease in the united states. Clin Infect Dis. 2009;49:e52-4.PubMed
9.
go back to reference Traina MI, Hernandez S, Sanchez DR, Dufani J, Salih M, Abuhamidah AM, et al Prevalence of Chagas disease in a U.S. Population of Latin American immigrants with conduction abnormalities on electrocardiogram. PLoS Negl Trop Dis. 2017;11:e0005244.PubMedPubMedCentral Traina MI, Hernandez S, Sanchez DR, Dufani J, Salih M, Abuhamidah AM, et al Prevalence of Chagas disease in a U.S. Population of Latin American immigrants with conduction abnormalities on electrocardiogram. PLoS Negl Trop Dis. 2017;11:e0005244.PubMedPubMedCentral
10.
go back to reference Kapelusznik L, Varela D, Montgomery SP, Shah AN, Steurer FJ, Rubinstein D, et al Chagas disease in Latin American immigrants with dilated cardiomyopathy in New York City. Clin Infect Dis. 2013;57:e7.PubMed Kapelusznik L, Varela D, Montgomery SP, Shah AN, Steurer FJ, Rubinstein D, et al Chagas disease in Latin American immigrants with dilated cardiomyopathy in New York City. Clin Infect Dis. 2013;57:e7.PubMed
11.
go back to reference Traina MI, Sanchez DR, Hernandez S, Bradfield JS, Labedi MR, Ngab TA, et al Prevalence and impact of Chagas disease among Latin American immigrants with nonischemic cardiomyopathy in Los Angeles, California. Circulation. 2015;8:938-43.PubMed Traina MI, Sanchez DR, Hernandez S, Bradfield JS, Labedi MR, Ngab TA, et al Prevalence and impact of Chagas disease among Latin American immigrants with nonischemic cardiomyopathy in Los Angeles, California. Circulation. 2015;8:938-43.PubMed
12.
go back to reference Dias E, Laranja FS, Miranda A, Nobrega G. Chagas’ disease; a clinical, epidemiologic, and pathologic study. Circulation. 1956;14:1035-60.PubMed Dias E, Laranja FS, Miranda A, Nobrega G. Chagas’ disease; a clinical, epidemiologic, and pathologic study. Circulation. 1956;14:1035-60.PubMed
13.
go back to reference Shikanai-Yasuda MA, Carvalho NB. Oral transmission of Chagas disease. Clin Infect Dis. 2012;54:845-52.PubMed Shikanai-Yasuda MA, Carvalho NB. Oral transmission of Chagas disease. Clin Infect Dis. 2012;54:845-52.PubMed
14.
go back to reference Healy C, Viles-Gonzalez JF, Saenz LC, Soto M, Ramirez JD, d’Avila A. Arrhythmias in chagasic cardiomyopathy. Cardiac Electrophysiol Clin. 2015;7:251-68. Healy C, Viles-Gonzalez JF, Saenz LC, Soto M, Ramirez JD, d’Avila A. Arrhythmias in chagasic cardiomyopathy. Cardiac Electrophysiol Clin. 2015;7:251-68.
15.
go back to reference Rassi A Jr, Rassi SG, Rassi A. Sudden death in Chagas’ disease. Arquivos brasileiros de cardiologia. 2001;76:75-96.PubMed Rassi A Jr, Rassi SG, Rassi A. Sudden death in Chagas’ disease. Arquivos brasileiros de cardiologia. 2001;76:75-96.PubMed
16.
go back to reference Rassi A Jr, Dias JC, Marin-Neto JA, Rassi A. Challenges and opportunities for primary, secondary, and tertiary prevention of Chagas’ disease. Heart. 2009;95:524-34.PubMed Rassi A Jr, Dias JC, Marin-Neto JA, Rassi A. Challenges and opportunities for primary, secondary, and tertiary prevention of Chagas’ disease. Heart. 2009;95:524-34.PubMed
17.
go back to reference Rassi A Jr, Rassi A, Little WC. Chagas’ heart disease. Clin Cardiol. 2000;23:883-9.PubMed Rassi A Jr, Rassi A, Little WC. Chagas’ heart disease. Clin Cardiol. 2000;23:883-9.PubMed
18.
go back to reference Rassi A Jr, Rassi A, Little WC, Xavier SS, Rassi SG, Rassi AG, et al Development and validation of a risk score for predicting death in Chagas’ heart disease. N Engl J Med. 2006;355:799-808.PubMed Rassi A Jr, Rassi A, Little WC, Xavier SS, Rassi SG, Rassi AG, et al Development and validation of a risk score for predicting death in Chagas’ heart disease. N Engl J Med. 2006;355:799-808.PubMed
19.
go back to reference Marin-Neto JA, Cunha-Neto E, Maciel BC, Simoes MV. Pathogenesis of chronic Chagas heart disease. Circulation. 2007;115:1109-23.PubMed Marin-Neto JA, Cunha-Neto E, Maciel BC, Simoes MV. Pathogenesis of chronic Chagas heart disease. Circulation. 2007;115:1109-23.PubMed
20.
go back to reference Cunha-Neto E, Bilate AM, Hyland KV, Fonseca SG, Kalil J, Engman DM. Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry. Autoimmunity. 2006;39:41-54.PubMed Cunha-Neto E, Bilate AM, Hyland KV, Fonseca SG, Kalil J, Engman DM. Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry. Autoimmunity. 2006;39:41-54.PubMed
21.
go back to reference Mangini S, Higuchi Mde L, Kawakami JT, Reis MM, Ikegami RN, Palomino SA, et al Infectious agents and inflammation in donated hearts and dilated cardiomyopathies related to cardiovascular diseases, Chagas’ heart disease, primary and secondary dilated cardiomyopathies. Int J Cardiol. 2015;178:55-62.PubMed Mangini S, Higuchi Mde L, Kawakami JT, Reis MM, Ikegami RN, Palomino SA, et al Infectious agents and inflammation in donated hearts and dilated cardiomyopathies related to cardiovascular diseases, Chagas’ heart disease, primary and secondary dilated cardiomyopathies. Int J Cardiol. 2015;178:55-62.PubMed
22.
go back to reference Torres FW, Acquatella H, Condado JA, Dinsmore R, Palacios IF. Coronary vascular reactivity is abnormal in patients with Chagas’ heart disease. Am Heart J. 1995;129:995-1001.PubMed Torres FW, Acquatella H, Condado JA, Dinsmore R, Palacios IF. Coronary vascular reactivity is abnormal in patients with Chagas’ heart disease. Am Heart J. 1995;129:995-1001.PubMed
23.
go back to reference Machado CR, Camargos ER, Guerra LB, Moreira MC. Cardiac autonomic denervation in congestive heart failure: comparison of Chagas’ heart disease with other dilated cardiomyopathy. Hum Pathol. 2000;31:3-10.PubMed Machado CR, Camargos ER, Guerra LB, Moreira MC. Cardiac autonomic denervation in congestive heart failure: comparison of Chagas’ heart disease with other dilated cardiomyopathy. Hum Pathol. 2000;31:3-10.PubMed
24.
go back to reference Villar JC, Leon H, Morillo CA. Cardiovascular autonomic function testing in asymptomatic t. Cruzi carriers: a sensitive method to identify subclinical Chagas’ disease. Int J Cardiol. 2004;93:189-95.PubMed Villar JC, Leon H, Morillo CA. Cardiovascular autonomic function testing in asymptomatic t. Cruzi carriers: a sensitive method to identify subclinical Chagas’ disease. Int J Cardiol. 2004;93:189-95.PubMed
25.
go back to reference Brasil PE, De Castro L, Hasslocher-Moreno AM, Sangenis LH, Braga JU. Elisa versus pcr for diagnosis of chronic Chagas disease: systematic review and meta-analysis. BMC Infect Dis. 2010;10:337.PubMedPubMedCentral Brasil PE, De Castro L, Hasslocher-Moreno AM, Sangenis LH, Braga JU. Elisa versus pcr for diagnosis of chronic Chagas disease: systematic review and meta-analysis. BMC Infect Dis. 2010;10:337.PubMedPubMedCentral
26.
go back to reference Marques J, Mendoza I, Noya B, Acquatella H, Palacios I, Marques-Mejias M. Ecg manifestations of the biggest outbreak of Chagas disease due to oral infection in latin-america. Arquivos brasileiros de cardiologia. 2013;101:249-54.PubMedPubMedCentral Marques J, Mendoza I, Noya B, Acquatella H, Palacios I, Marques-Mejias M. Ecg manifestations of the biggest outbreak of Chagas disease due to oral infection in latin-america. Arquivos brasileiros de cardiologia. 2013;101:249-54.PubMedPubMedCentral
27.
go back to reference Velasco A, Velasco VM, Rosas F, Cevik C, Morillo CA. Utility of the navx(r) electroanatomic mapping system for permanent pacemaker implantation in a pregnant patient with Chagas disease. Indian Pacing Electrophysiol J. 2013;13:34-7.PubMedPubMedCentral Velasco A, Velasco VM, Rosas F, Cevik C, Morillo CA. Utility of the navx(r) electroanatomic mapping system for permanent pacemaker implantation in a pregnant patient with Chagas disease. Indian Pacing Electrophysiol J. 2013;13:34-7.PubMedPubMedCentral
28.
go back to reference Acquatella H, Asch FM, Barbosa MM, Barros M, Bern C, Cavalcante JL, et al Recommendations for multimodality cardiac imaging in patients with Chagas disease: a report from the american society of echocardiography in collaboration with the interamerican association of echocardiography (ecosiac) and the cardiovascular imaging department of the brazilian society of cardiology (dic-sbc). J Am Soc Echocardiogr. 2018;31:3-25.PubMed Acquatella H, Asch FM, Barbosa MM, Barros M, Bern C, Cavalcante JL, et al Recommendations for multimodality cardiac imaging in patients with Chagas disease: a report from the american society of echocardiography in collaboration with the interamerican association of echocardiography (ecosiac) and the cardiovascular imaging department of the brazilian society of cardiology (dic-sbc). J Am Soc Echocardiogr. 2018;31:3-25.PubMed
29.
go back to reference Baranchuk A, Femenia F, Lopez-Diez JC, Muratore C, Valentino M, Retyk E, et al Fragmented surface ecg was a poor predictor of appropriate therapies in patients with chagas’ cardiomyopathy and icd implantation (fragmented ecg in Chagas’ cardiomyopathy study). Ann Noninvasive Electrocardiol. 2014;19:43-9.PubMed Baranchuk A, Femenia F, Lopez-Diez JC, Muratore C, Valentino M, Retyk E, et al Fragmented surface ecg was a poor predictor of appropriate therapies in patients with chagas’ cardiomyopathy and icd implantation (fragmented ecg in Chagas’ cardiomyopathy study). Ann Noninvasive Electrocardiol. 2014;19:43-9.PubMed
30.
go back to reference Acquatella H. Echocardiography in Chagas heart disease. Circulation. 2007;115:1124-31.PubMed Acquatella H. Echocardiography in Chagas heart disease. Circulation. 2007;115:1124-31.PubMed
31.
go back to reference Torreao JA, Ianni BM, Mady C, Naia E, Rassi CH, Nomura C, et al Myocardial tissue characterization in Chagas’ heart disease by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2015;17:97.PubMedPubMedCentral Torreao JA, Ianni BM, Mady C, Naia E, Rassi CH, Nomura C, et al Myocardial tissue characterization in Chagas’ heart disease by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2015;17:97.PubMedPubMedCentral
32.
go back to reference Rochitte CE, Oliveira PF, Andrade JM, Ianni BM, Parga JR, Avila LF, et al Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas’ disease: a marker of disease severity. J Am Coll Cardiol. 2005;46:1553-8.PubMed Rochitte CE, Oliveira PF, Andrade JM, Ianni BM, Parga JR, Avila LF, et al Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas’ disease: a marker of disease severity. J Am Coll Cardiol. 2005;46:1553-8.PubMed
33.
go back to reference Hiss FC, Lascala TF, Maciel BC, Marin-Neto JA, Simoes MV. Changes in myocardial perfusion correlate with deterioration of left ventricular systolic function in chronic Chagas’ cardiomyopathy. JACC Cardiovasc Imaging. 2009;2:164-72.PubMed Hiss FC, Lascala TF, Maciel BC, Marin-Neto JA, Simoes MV. Changes in myocardial perfusion correlate with deterioration of left ventricular systolic function in chronic Chagas’ cardiomyopathy. JACC Cardiovasc Imaging. 2009;2:164-72.PubMed
34.
go back to reference Peix A, Garcia R, Sanchez J, Cabrera LO, Padron K, Vedia O, et al Myocardial perfusion imaging and cardiac involvement in the indeterminate phase of Chagas disease. Arquivos brasileiros de cardiologia. 2013;100:114-7.PubMed Peix A, Garcia R, Sanchez J, Cabrera LO, Padron K, Vedia O, et al Myocardial perfusion imaging and cardiac involvement in the indeterminate phase of Chagas disease. Arquivos brasileiros de cardiologia. 2013;100:114-7.PubMed
35.
go back to reference Simoes MV, Pintya AO, Bromberg-Marin G, Sarabanda AV, Antloga CM, Pazin-Filho A, et al Relation of regional sympathetic denervation and myocardial perfusion disturbance to wall motion impairment in Chagas’ cardiomyopathy. Am J Cardiol. 2000;86:975-81.PubMed Simoes MV, Pintya AO, Bromberg-Marin G, Sarabanda AV, Antloga CM, Pazin-Filho A, et al Relation of regional sympathetic denervation and myocardial perfusion disturbance to wall motion impairment in Chagas’ cardiomyopathy. Am J Cardiol. 2000;86:975-81.PubMed
36.
go back to reference Gadioli LP, Miranda CH, Pintya AO, de Figueiredo AB, Schmidt A, Maciel BC, et al The severity of ventricular arrhythmia correlates with the extent of myocardial sympathetic denervation, but not with myocardial fibrosis extent in chronic Chagas cardiomyopathy : Chagas disease, denervation and arrhythmia. J Nucl Cardiol. 2018;25:75-83.PubMed Gadioli LP, Miranda CH, Pintya AO, de Figueiredo AB, Schmidt A, Maciel BC, et al The severity of ventricular arrhythmia correlates with the extent of myocardial sympathetic denervation, but not with myocardial fibrosis extent in chronic Chagas cardiomyopathy : Chagas disease, denervation and arrhythmia. J Nucl Cardiol. 2018;25:75-83.PubMed
38.
go back to reference Pinazo MJ, Munoz J, Posada E, Lopez-Chejade P, Gallego M, Ayala E, et al Tolerance of benznidazole in treatment of Chagas’ disease in adults. Antimicrob Agents Chemother. 2010;54:4896-9.PubMedPubMedCentral Pinazo MJ, Munoz J, Posada E, Lopez-Chejade P, Gallego M, Ayala E, et al Tolerance of benznidazole in treatment of Chagas’ disease in adults. Antimicrob Agents Chemother. 2010;54:4896-9.PubMedPubMedCentral
39.
go back to reference Russomando G, de Tomassone MM, de Guillen I, Acosta N, Vera N, Almiron M, et al Treatment of congenital Chagas’ disease diagnosed and followed up by the polymerase chain reaction. Am J Trop Med Hyg. 1998;59:487-91.PubMed Russomando G, de Tomassone MM, de Guillen I, Acosta N, Vera N, Almiron M, et al Treatment of congenital Chagas’ disease diagnosed and followed up by the polymerase chain reaction. Am J Trop Med Hyg. 1998;59:487-91.PubMed
40.
go back to reference de Andrade AL, Zicker F, de Oliveira RM, Almeida Silva S, Luquetti A, Travassos LR, et al Randomised trial of efficacy of benznidazole in treatment of early trypanosoma cruzi infection. Lancet. 1996;348:1407-13.PubMed de Andrade AL, Zicker F, de Oliveira RM, Almeida Silva S, Luquetti A, Travassos LR, et al Randomised trial of efficacy of benznidazole in treatment of early trypanosoma cruzi infection. Lancet. 1996;348:1407-13.PubMed
41.
go back to reference Bern C, Montgomery SP, Herwaldt BL, Rassi A Jr, Marin-Neto JA, Dantas RO, et al Evaluation and treatment of Chagas disease in the united states: a systematic review. JAMA. 2007;298:2171-81.PubMed Bern C, Montgomery SP, Herwaldt BL, Rassi A Jr, Marin-Neto JA, Dantas RO, et al Evaluation and treatment of Chagas disease in the united states: a systematic review. JAMA. 2007;298:2171-81.PubMed
42.
go back to reference Andrade JP, Marin-Neto JA, Paola AA, Vilas-Boas F, Oliveira GM, Bacal F, et al Sociedade Brasileira de Cardiologia IDLApoDeTdCC [i latin american guidelines for the diagnosis and treatment of Chagas cardiomyopathy]. Arquivos brasileiros de cardiologia. 2011;97:1-48.PubMed Andrade JP, Marin-Neto JA, Paola AA, Vilas-Boas F, Oliveira GM, Bacal F, et al Sociedade Brasileira de Cardiologia IDLApoDeTdCC [i latin american guidelines for the diagnosis and treatment of Chagas cardiomyopathy]. Arquivos brasileiros de cardiologia. 2011;97:1-48.PubMed
43.
go back to reference Morillo CA, Marin-Neto JA, Avezum A, Sosa-Estani S, Rassi A Jr, Rosas F, et al Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy. N Engl J Med. 2015;373:1295-306.PubMed Morillo CA, Marin-Neto JA, Avezum A, Sosa-Estani S, Rassi A Jr, Rosas F, et al Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy. N Engl J Med. 2015;373:1295-306.PubMed
44.
go back to reference Pinto-Martinez A, Hernandez-Rodriguez V, Rodriguez-Duran J, Hejchman E, Benaim G. Anti-trypanosoma cruzi action of a new benzofuran derivative based on amiodarone structure. Exp Parasitol. 2018;189:8-15.PubMed Pinto-Martinez A, Hernandez-Rodriguez V, Rodriguez-Duran J, Hejchman E, Benaim G. Anti-trypanosoma cruzi action of a new benzofuran derivative based on amiodarone structure. Exp Parasitol. 2018;189:8-15.PubMed
45.
go back to reference Marin-Neto JA, Rassi A Jr, Morillo CA, Avezum A, Connolly SJ, Sosa-Estani S, et al Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas’ cardiomyopathy: the benznidazole evaluation for interrupting trypanosomiasis (benefit). Am Heart J. 2008;156:37-43.PubMed Marin-Neto JA, Rassi A Jr, Morillo CA, Avezum A, Connolly SJ, Sosa-Estani S, et al Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas’ cardiomyopathy: the benznidazole evaluation for interrupting trypanosomiasis (benefit). Am Heart J. 2008;156:37-43.PubMed
46.
go back to reference Martinelli M, de Siqueira SF, Sternick EB, Rassi A Jr, Costa R, Ramires JA, et al Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in Chagas’ heart disease. Am J Cardiol. 2012;110:1040-5.PubMed Martinelli M, de Siqueira SF, Sternick EB, Rassi A Jr, Costa R, Ramires JA, et al Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in Chagas’ heart disease. Am J Cardiol. 2012;110:1040-5.PubMed
47.
go back to reference Henzdo BD, do Nascimento TA, Dietrich CDO, Dalegrave C, Hernandes V, Mesas CE, et al Simultaneous epicardial and endocardial substrate mapping and radiofrequency catheter ablation as first-line treatment for ventricular tachycardia and frequent icd shocks in chronic chagasic cardiomyopathy. J Interv Cardiac Electrophysiol. 2009;26:195-205. Henzdo BD, do Nascimento TA, Dietrich CDO, Dalegrave C, Hernandes V, Mesas CE, et al Simultaneous epicardial and endocardial substrate mapping and radiofrequency catheter ablation as first-line treatment for ventricular tachycardia and frequent icd shocks in chronic chagasic cardiomyopathy. J Interv Cardiac Electrophysiol. 2009;26:195-205.
48.
go back to reference Saenz LC, Corrales FM, Bautista W, Traina M, Meymandi S, Rodriguez DA, et al Cardiac sympathetic denervation for intractable ventricular arrhythmias in Chagas disease. Heart Rhythm. 2016;13:1388-94.PubMed Saenz LC, Corrales FM, Bautista W, Traina M, Meymandi S, Rodriguez DA, et al Cardiac sympathetic denervation for intractable ventricular arrhythmias in Chagas disease. Heart Rhythm. 2016;13:1388-94.PubMed
49.
go back to reference Armaganijan LV, Staico R, Moreira DA, Lopes RD, Medeiros PT, Habib R, et al 6-month outcomes in patients with implantable cardioverter-defibrillators undergoing renal sympathetic denervation for the treatment of refractory ventricular arrhythmias. JACC Cardiovasc Interv. 2015;8:984-90.PubMed Armaganijan LV, Staico R, Moreira DA, Lopes RD, Medeiros PT, Habib R, et al 6-month outcomes in patients with implantable cardioverter-defibrillators undergoing renal sympathetic denervation for the treatment of refractory ventricular arrhythmias. JACC Cardiovasc Interv. 2015;8:984-90.PubMed
Metadata
Title
Chagas heart disease: A contemporary review
Authors
Alejandro Velasco, MD
Carlos A. Morillo, MD
Publication date
01-04-2020
Publisher
Springer International Publishing
Published in
Journal of Nuclear Cardiology / Issue 2/2020
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-018-1361-1

Other articles of this Issue 2/2020

Journal of Nuclear Cardiology 2/2020 Go to the issue